Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study

被引:3
|
作者
Ghosh, Subrata [1 ,2 ]
Antunes, Ana [3 ,9 ]
Rinta-Kokko, Hanna [4 ]
Chaparova, Elena [5 ]
Lay-Flurrie, Sarah [6 ]
Tricotel, Aurore [7 ]
Andersson, Fredrik L. [8 ]
机构
[1] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[2] Univ Birmingham, Birmingham, England
[3] IQVIA, Real World Solut, Global Database Studies, Lisbon, Portugal
[4] IQVIA, Real World Solut, Global Database Studies, Espoo, Finland
[5] IQVIA, Real World Solut, Sofia, Bulgaria
[6] IQVIA, Real World Solut, London, England
[7] IQVIA, Real World Solut, Paris, France
[8] Ferring Pharmaceut, Copenhagen, Denmark
[9] IQVIA, Lagoas Pk,Edificio 3, P-2740266 Lisbon, Portugal
关键词
Clostridioides difficile infection; Recurrent clostridioides difficile infection; Epidemiological; Real-world study; England; RECUR; RISK; DISEASE;
D O I
10.1016/j.ijid.2024.01.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To estimate the epidemiological and clinical burden of Clostridioides difficile infections (CDIs) and recurrences (rCDIs) in England. Methods: This retrospective study included adult patients diagnosed with CDI (community or hospital settings) over 2015-2019 from Clinical Practice Research Datalink and Hospital Episode Statistics databases. Incidences of CDI and rCDI were determined annually. Time to subsequent rCDI was estimated by Kaplan-Meier method. Rates of complications were assessed within 12 months from index episode. Association of risk factors with complications was evaluated using a Cox regression model. Results: A total of 52,443 CDI episodes were recorded among 36,913 patients. Of these, 75% were aged >= 65 years, 59% were women; 73% were treated in community settings. CDI incidence remained stable (111 episodes per 10 0,0 0 0 patients in 2019). Around 21% of patients had >= 1 rCDI. Sepsis (12%) was the most common complication, followed by colectomy and ulcerative colitis. Age, gender, comorbidities, rCDI, preindex medical procedures, hospitalizations and consultations, and CDI treatment in hospital, were found to increase the risk of complication. Conclusions: CDI remains a concern in England. The study highlights the importance of managing primary and rCDI episodes via effective and improved therapies to prevent fatal complications. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [31] Secukinumab Treatment in Patients with Hidradenitis Suppurativa in Real-World Clinical Settings: A Multicenter Study
    Erbagci, Ece
    Bakay, Ozge Sevil Karstarli
    Hapa, Fatma Asli
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2025, 15 (01):
  • [32] Yield of clinical metagenomics: insights from real-world practice for tissue infections
    Tang, Hui
    Chen, Yuqing
    Tang, Xinyan
    Wei, Muyun
    Hu, Juan
    Zhang, Xuan
    Xiang, Dairong
    Yang, Qing
    Han, Dongsheng
    EBIOMEDICINE, 2025, 111
  • [33] Characteristics and Real-World Outcomes of Patients Treated with Fecal Microbiota, Live-js']jslm (RBL) for the Prevention of Recurrent Clostridioides difficile Infection
    Khanna, Sahil
    Seo, Sanghyuk
    Yang, Min
    Garcia-Horton, Viviana
    Gao, Yipeng
    Kim, Hannah H.
    Ormenaj, Loren
    Guo, Amy
    INFECTIOUS DISEASES AND THERAPY, 2025, : 793 - 802
  • [34] Improvement of Clinical Outcomes in Severe Eosinophilic Asthma Patients Treated with Benralizumab in Real-World Clinical Practice in England: XALOC Study Programme
    Jackson, D.
    Dube, S.
    Morris, T.
    Hassan, B.
    Pfeffer, P. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [35] Real-world clinical outcomes of meropenem/vaborbactam for treatment of carbapenem-resistant Enterobacterales infections
    Zhang, Helen L.
    Cressman, Leigh
    Lautenbach, Ebbing
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 : 299 - 302
  • [36] Allergen immunotherapy: clinical outcomes data from a real-world clinical practice.
    Silva, P. M.
    Raposo, C. M.
    Nogueira, C.
    ALLERGY, 2021, 76 : 36 - 37
  • [37] Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study
    Dasari, Arvind
    Bergsland, Emily K.
    Benson, Al B.
    Cai, Beilei
    Huynh, Lynn
    Totev, Todor
    Shea, Jerome
    Duh, Mei Sheng
    Neary, Maureen P.
    Dagohoy, Cecile G.
    Shih, Brandon E.
    Maurer, Victoria E.
    Chan, Jennifer
    Kulke, Matthew H.
    ONCOLOGIST, 2019, 24 (08): : 1066 - 1075
  • [38] A Systematic Literature Review of Clinical and Economic Outcomes for Patients with Paroxysmal Nocturnal Hemoglobinuria in Clinical Trials and Real-World Settings
    Waheed, Anem
    Kaufhold, Samantha
    Liu, Che-Rung
    Lei, Jiali
    Nellesen, Dave
    Geevarghese, Anumaxine Lincy
    Yen, Glorian P.
    BLOOD, 2022, 140 : 11451 - 11452
  • [39] IMPACT OF THE CHOICE OF CLINICAL CODE SET ON THE OUTCOMES OF A REAL-WORLD DATABASE STUDY
    Artignan, A.
    Buchanan-Hughes, A.
    VALUE IN HEALTH, 2020, 23 : S324 - S324
  • [40] Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study
    Tran, Trung N.
    Kerkhof, Marjan
    Carter, Victoria
    Price, David B.
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 727 - 742